Clinical study of preemptive sedation with remimazolam on prevention of propofol injection pain in induced abortion / curettage patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041805

Enrollment

Unknown

Registered

2021-01-06

Start date

2021-01-05

Completion date

Unknown

Last updated

2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Pro+NS:NS

Pro+Lido:Lidocaine

Pro+Remi:Reminazolam

Eligibility

Sex/Gender

Female

Age

16 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 210 patients scheduled for painless induced abortion / curettage under general anesthesia were selected; 2. Aged 18-60 years, ASA I-II.

Exclusion criteria

Exclusion criteria: 1. Subjects with liver and kidney dysfunction; 2. Subjects who are allergic to the drugs studied; 3. Subjectswith nervous system or cardiovascular diseases; 4. Obese subjects; 5. Subjects with difficult airway; 6. Subjects taking analgesics.

Design outcomes

Primary

Measure	Time frame
pain;	—

Secondary

Measure	Time frame
pain scores;	—

Countries

China

Contacts

Public ContactXuehai Guan

The First Affiliated Hospital of Guangxi Medical University

guan_xh@aliyun.com+86 18587697310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026